+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intranasal Drug & Vaccine Delivery Market by Drug Type (Analgesics, Antihistamines, Steroids), Formulation Type (Gel Formulations, Liquid Formulations, Powder Formulations), Device Type, Dosage, Application, End-User - Global Forecast 2025-2030- Product Image
Intranasal Drug & Vaccine Delivery Market by Drug Type (Analgesics, Antihistamines, Steroids), Formulation Type (Gel Formulations, Liquid Formulations, Powder Formulations), Device Type, Dosage, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Intranasal Drug & Vaccine Delivery Market by Drug Type (Analgesics, Antihistamines, Steroids), Formulation Type (Gel Formulations, Liquid Formulations, Powder Formulations), Device Type, Dosage, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533387
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The intranasal drug and vaccine delivery market is advancing rapidly, reshaping therapeutic and immunization strategies for pharmaceutical stakeholders. This transformation is fueled by novel noninvasive solutions, disruptive device technologies, and an expanding array of patient-centric drug formulations that optimize healthcare delivery in varied settings.

Market Snapshot: Intranasal Drug & Vaccine Delivery

The intranasal drug and vaccine delivery market grew from USD 49.59 billion in 2024 to USD 52.43 billion in 2025. It is expected to continue growing at a CAGR of 5.94%, reaching USD 70.12 billion by 2030. This steady growth is fueled by a convergence of pharmaceutical innovation, regulatory alignment, and changing preferences for non-injectable therapies. As demand for needle-free delivery rises, and public health initiatives emphasize broad access, intranasal solutions are achieving increased adoption across both established and emerging regions worldwide.

Scope & Segmentation: Key Components of the Intranasal Delivery Market

  • Drug Types: Analgesics including non-opioids and opioids; antihistamines; steroids; a range of vaccines such as inactivated, live attenuated, and mRNA-based formulations.
  • Formulation Types: Gel formulations for extended retention; liquid formulations for rapid absorption; powder formulations designed for enhanced product stability and efficient distribution.
  • Device Types: Atomizers ensuring fine mist application; nasal droppers suitable for simple dosing; nasal sprays offering user-friendly administration.
  • Dosage Formats: Multi-dose systems for repeated use; unit-dose devices optimized for sterility and convenience.
  • Application Domains: Allergy treatment, hormone replacement, neurological conditions, pain management, psychiatric disorders, and broader therapeutic drug delivery purposes.
  • End-User Networks: Solutions designed for homecare environments; targeted offerings for hospitals and clinics; platforms supporting research and academic needs.
  • Regions: Coverage across the Americas (with detailed focus on major U.S. states and Latin America), Europe, Middle East & Africa (including Western Europe, Gulf States, and Sub-Saharan Africa), and Asia-Pacific (with detailed attention to leading markets such as China, India, and Japan).
  • Industry Players: Key participation from Altimmune, Inc., AptarGroup, Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bayer AG, Becton, Dickinson, and Company, Bharat Biotech Ltd., Boehringer Ingelheim International GmbH, and others shaping new standards in device engineering and therapeutic delivery.

Key Takeaways for Decision-Makers

  • Intranasal delivery is being redefined as a primary therapeutic and preventative modality, particularly in environments where patient compliance and noninvasiveness drive product adoption.
  • Next-generation device innovations—such as adaptive spray nozzles and digital integration for dose tracking—are accelerating the real-world usability and market reach of intranasal solutions.
  • Customization of formulations, especially for vaccines and neurological applications, is a central trend as companies seek to address stability and dosing challenges across climates and geographies.
  • Strategic alliances—spanning pharmaceutical, device, biotech, and logistics partners—are proving crucial for scaling production, optimizing supply chains, and expanding into new healthcare markets.
  • The regulatory environment has grown more accommodating, with clear guidelines facilitating faster approval cycles and smoother commercialization of nasal delivery products.

Tariff Impact: Navigating New U.S. Trade Measures

The introduction of U.S. tariffs in 2025 has initiated swift adaptations in procurement and manufacturing strategies throughout the intranasal therapeutics supply chain. Organizations are strengthening resilience by exploring local manufacturing, diversifying supplier portfolios, and optimizing cross-border logistics in response to cost increases in imported components and excipients. This shift is spurring both investment in domestic R&D as well as the reconfiguration of global sourcing models to maintain product availability and minimize disruption to patient care.

Methodology & Data Sources

This report draws on a mixed-methods approach, integrating structured industry interviews, regulatory analysis, patent landscape review, and qualitative expert validation. Data triangulation enhances reliability, while comparative analysis of device performance and scenario-based supply chain evaluations inform actionable recommendations for intranasal product development.

Why This Report Matters

  • Delivers insight into how advanced device-engineering and formulation strategies are shaping the future of intranasal therapeutics and vaccines.
  • Equips leaders with region-specific analysis and actionable benchmarks to inform procurement, regulatory engagement, and R&D investment decisions.
  • Supports strategic planning by illuminating critical supply chain trends, market entry considerations, and evolving end-user demands across global healthcare systems.

Conclusion

The intranasal drug and vaccine delivery market is entering a new phase of strategic relevance, driven by innovation, regulatory evolution, and product differentiation. Industry stakeholders who pivot quickly—aligning investments with these shifts—will effectively shape the next era of targeted pharmaceutical care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in mucoadhesive polymer systems for prolonged intranasal drug residence time
5.2. Utilization of aerosolized nanocarriers for enhanced brain-targeted delivery through the nasal route
5.3. Integration of 3D printing techniques for personalized intranasal dosage form fabrication
5.4. Clinical progress of live attenuated intranasal COVID-19 vaccines showing improved mucosal immunity
5.5. Emerging intranasal migraine therapies leveraging rapid onset small molecule formulations
5.6. Expansion of intranasal insulin sprays for neurodegenerative disease treatment in clinical trials
5.7. Scaled manufacturing of dry powder nasal vaccines using advanced spray freeze drying technologies
5.8. Collaboration between pharmaceutical and device manufacturers to optimize nasal spray delivery systems
5.9. Adoption of real-time imaging techniques to monitor intranasal deposition and absorption profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intranasal Drug & Vaccine Delivery Market, by Drug Type
8.1. Introduction
8.2. Analgesics
8.2.1. Non-opioids
8.2.2. Opioids
8.3. Antihistamines
8.4. Steroids
8.5. Vaccines
8.5.1. Inactivated Vaccines
8.5.2. Live Attenuated Vaccines
8.5.3. mRNA-based Vaccine
9. Intranasal Drug & Vaccine Delivery Market, by Formulation Type
9.1. Introduction
9.2. Gel Formulations
9.3. Liquid Formulations
9.4. Powder Formulations
10. Intranasal Drug & Vaccine Delivery Market, by Device Type
10.1. Introduction
10.2. Atomizer
10.3. Nasal Dropper
10.4. Nasal Spray
11. Intranasal Drug & Vaccine Delivery Market, by Dosage
11.1. Introduction
11.2. Multi-dose
11.3. Unit-dose
12. Intranasal Drug & Vaccine Delivery Market, by Application
12.1. Introduction
12.2. Allergy Treatment
12.3. Hormone Replacement
12.4. Neurological Conditions
12.5. Pain Management
12.6. Psychiatric Disorders
12.7. Therapeutic Drug Delivery
13. Intranasal Drug & Vaccine Delivery Market, by End-User
13.1. Introduction
13.2. Homecare
13.3. Hospitals & Clinics
13.4. Research & Academic Institution
14. Americas Intranasal Drug & Vaccine Delivery Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Intranasal Drug & Vaccine Delivery Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Intranasal Drug & Vaccine Delivery Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Altimmune, Inc.
17.3.2. AptarGroup, Inc.
17.3.3. AstraZeneca PLC
17.3.4. Bausch Health Companies Inc.
17.3.5. Bayer AG
17.3.6. Becton, Dickinson, and Company
17.3.7. Bharat Biotech Ltd.
17.3.8. Boehringer Ingelheim International GmbH.
17.3.9. Catalent, Inc
17.3.10. DCA Design International Limited
17.3.11. Emergent BioSolutions Inc.
17.3.12. GlaxoSmithKline PLC
17.3.13. Hovione Limited
17.3.14. Impel Pharmaceuticals LLC.
17.3.15. Indivior PLC
17.3.16. Intersect ENT by Medtronic plc
17.3.17. Intertek Group PLC
17.3.18. Johnson & Johnson Services, Inc.
17.3.19. Kindeva Drug Delivery L.P.
17.3.20. Merck & Co., Inc.
17.3.21. Neurelis, Inc.
17.3.22. Novartis AG
17.3.23. OptiNose, Inc.
17.3.24. Pfizer Inc.
17.3.25. Recipharm AB.
17.3.26. Sanofi S.A.
17.3.27. Teleflex Incorporated
17.3.28. Teva Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. INTRANASAL DRUG & VACCINE DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INTRANASAL DRUG & VACCINE DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INTRANASAL DRUG & VACCINE DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INTRANASAL DRUG & VACCINE DELIVERY MARKET: RESEARCHAI
FIGURE 28. INTRANASAL DRUG & VACCINE DELIVERY MARKET: RESEARCHSTATISTICS
FIGURE 29. INTRANASAL DRUG & VACCINE DELIVERY MARKET: RESEARCHCONTACTS
FIGURE 30. INTRANASAL DRUG & VACCINE DELIVERY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INTRANASAL DRUG & VACCINE DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MRNA-BASED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MRNA-BASED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY GEL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY GEL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY POWDER FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY POWDER FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ATOMIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ATOMIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL DROPPER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL DROPPER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MULTI-DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY UNIT-DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY UNIT-DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ALLERGY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ALLERGY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY THERAPEUTIC DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY THERAPEUTIC DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 116. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 117. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 118. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 119. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 124. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 125. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 134. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 135. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 212. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 213. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 216. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 217. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 228. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 229. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 232. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 233. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 260. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 261. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 262. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 263. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 264. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 265. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 266. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 267. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 268. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 269. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 270. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 271. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 276. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 277. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 280. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 281. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 284. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 285. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 286. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 287. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 290. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE D

Samples

Loading
LOADING...

Companies Mentioned

  • Altimmune, Inc.
  • AptarGroup, Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bayer AG
  • Becton, Dickinson, and Company
  • Bharat Biotech Ltd.
  • Boehringer Ingelheim International GmbH.
  • Catalent, Inc
  • DCA Design International Limited
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline PLC
  • Hovione Limited
  • Impel Pharmaceuticals LLC.
  • Indivior PLC
  • Intersect ENT by Medtronic plc
  • Intertek Group PLC
  • Johnson & Johnson Services, Inc.
  • Kindeva Drug Delivery L.P.
  • Merck & Co., Inc.
  • Neurelis, Inc.
  • Novartis AG
  • OptiNose, Inc.
  • Pfizer Inc.
  • Recipharm AB.
  • Sanofi S.A.
  • Teleflex Incorporated
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 52.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 70.12 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Intranasal Drug and Vaccine Delivery Market Size, Share & Trends Analysis Report by Product, Dosage, Application, Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Intranasal Drug and Vaccine Delivery Market Size, Share & Trends Analysis Report by Product, Dosage, Application, Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Vaccine Delivery Devices - Global Strategic Business Report - Product Image

Vaccine Delivery Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Vaccine Delivery Devices Market by Device Type (Auto-Injectors, Infusion Pumps, Jet Injectors), Administration Route (Intradermal Injection, Intramuscular Injection, Intravenous Injection), End User, Product Form - Global Forecast 2025-2030 - Product Image

Vaccine Delivery Devices Market by Device Type (Auto-Injectors, Infusion Pumps, Jet Injectors), Administration Route (Intradermal Injection, Intramuscular Injection, Intravenous Injection), End User, Product Form - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Global Vaccine Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Vaccine Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Vaccine Delivery Devices Market Size, Share & Trends Analysis Report By Device (Syringes, Jet Injectors), By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Vaccine Delivery Devices Market Size, Share & Trends Analysis Report By Device (Syringes, Jet Injectors), By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.